Amy Valley is a Vice President, Strategic Roadmap and Execution, Specialty Networks Solutions at Cardinal Health. Colleagues describe them as "I had the privilege of working directly with Amy many years ago, and throughout the years her passion for oncology, innovation and patient care has continued her impact within the industry. Amy consistently demonstrates a keen ability to translate clinical insights into operation excellence, driving innovative strategies that deliver value across stakeholders. Her approah is both thoughtful and collaborative, fostering strong relationships and thoughtful leadership that ensures alignment toward common goals. It's been a pleasure to stay connected and see her influence expand and leadership recognized within Cardinal Health.", "Amy is the key to unlocking an understanding of the dynamics in the oncology commercial marketplace. Not only is she a fresh and creative strategic thinker, Amy is also an experienced multi-disciplinary team leader who takes a holistic view of value generation with outstanding results. Her leadership motivates others to be their best. Cardinal Health is lucky to have a Amy as one of their high performers.", and "I am pleased to recommend Amy Valley, Vice President of Clinical Strategy and Technology Solutions at Cardinal Health. Amy's expertise and visionary leadership have been pivotal in integrating cutting-edge technologies into oncology practices, enhancing both the quality and cost-effectiveness of patient care. Her strategic foresight was notably instrumental in forging a transformative partnership with CureMD. I met Amy for the first time at the ASCO 2019 meeting. It was that inspirational session that led to this wonderful collaboration. From its inception, this initiative has focused on innovative tech solutions that improve patient outcomes and support value-based care models for community oncology. Amy plays a pivotal role as a core member of the leadership committee that continuously seeks to enhance and expand the benefits of this partnership. Furthermore, Amy has exceptional skills in managing specialty GPOs and developing tech solutions that have a profound impact on healthcare delivery. Her ability to effectively partner with specialty pharmaceutical manufacturers and navigate the complex landscape of drug costs and healthcare technology demonstrates a deep commitment to advancing healthcare. Amy’s contributions to the field extend to her thoughtful consideration of financial toxicity in cancer treatment. Through tools like Decision Path, she envisions oncologists providing cost-effective care without compromising treatment quality. This tool exemplifies her focus on real-time solutions that integrate seamlessly into clinical workflows, ensuring that financial considerations are as accessible as medical guidelines. Amy Valley is a true industry leader whose work continually influences the specialty pharmaceutical landscape. I wholeheartedly endorse Amy for her continued contributions to the health tech industry and am confident in her ongoing impact."